Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Standardized extract providing 50-100mg harpagoside daily (≈600-2400mg extract)
with-meals
Harpagoside-standardized extract
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
2-8 weeks
2-8 weeks
Days
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review.
BMC complementary and alternative medicine (2004) · Systematic review
Twelve trials reviewed across OA and low-back pain
Herbal Medicine for Low Back Pain: A Cochrane Review.
Spine (2016) · Systematic review
14 RCTs (2050 participants) of herbal medicines for low-back pain
Herbal medicine for low-back pain.
The Cochrane database of systematic reviews (2014) · Systematic review
Devil's claw standardized to 50-100mg harpagoside may beat placebo short-term
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 5.5/10) and wins in 3 of 3 categories.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 50).
No known interactions between Devil's Claw and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.